Lymphomatoid papulosis and Hodgkin's disease: report of a case.
The authors report the case of a 67-year-old-man who presented with stage IIIAa Hodgkin's disease (HD) almost 17 years after developing CD30+ type A lymphomatoid papulosis (LP). Combination chemotherapy resulted in a complete remission of the HD for 2 years, although the LP continued relentlessly as before. A possible link between HD and LP is discussed in the light of similar cases reported in the literature.
Koeppel
M C
MC
Department of Dermatology, Institut Paoli-Calmettes, Marseille, France.
Horschowski
N
N
Terrier
G
G
Andrac
L
L
Stoppa
A M
AM
Signoret
R
R
Sayag
J
J
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D017731:Lymphomatoid Papulosis / Q000473:pathology*; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D011230:Precancerous Conditions; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D016539:Reed-Sternberg Cells / Q000473:pathology*; D013997:Time Factors; D014747:Vinblastine; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone